FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
215431NDAAXSOME001SYMBRAVOTABLET;ORAL20MG;EQ 10MG BASEMELOXICAM; RIZATRIPTAN BENZOATE2025-01-30PrescriptionYes
215430NDAAXSOME001AUVELITYTABLET, EXTENDED RELEASE;ORAL105MG;45MGBUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE2022-08-18PrescriptionYes